Extract of Fungi of Huaier used for triple negtive breast cancer- a prospective randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001250

Enrollment

Unknown

Registered

2011-01-07

Start date

2011-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Triple negtive breast cancer

Interventions

Group A:Extract of Fungi of Huaier

Group B:Blank

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Patients were diagnosed with breast from stage I-III (clinical stage) and IHE tests:ER(-), PR(-), HER-2/neu(-); 3. Patients for modified radical mastectomy less than one year ; 4. ECOG score must be 0 or 1 ; 5. No other malignancy ; 6. Be able to follow the scheme; 7. The patients agree to participate in the trials and sign the informed consent and date.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating female patients; 2. Complicated serious disease(such as:heart disease?liver disease?kidney disease,etc)for exist less than 2 years by estimate; 3. Patients with a history of Extract of Fungi of Huaier allergy; 4. Karnofsky Score less than 60 ; 5. Patients who are not convenient to go to the doctors' office for recheck for any reason; 6. The researchers believe that the patients are not suitable for this clinical trial for other reasons.

Design outcomes

Primary

Measure	Time frame
5 years survival Rate;relapse/ metastasize Rate; overall survival rate;	—

Countries

China

Contacts

Public ContactJun Jiang

jcbd@medmail.com.cn+86 23 68765633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026